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Abstract— Medical devices and computerized medical 
applications are exponentially increasing nowadays. This is 
actively supported by the EU’s personalized healthcare     
m-Health and e-Health research programs. The core of such 
researches is represented undoubtedly by the basic field of 
biomedical engineering, the physiological modeling, 
simulation and control topic. In 2013 the Physiological 
Controls Group of the Obuda University was created in 
order to integrate in a structural form the university 
researches in this sense and linking them with educational 
programs as well. The presentation gives an overview of the 
obtained results focusing on diabetes, tumor and 
hemodialysis, but presenting biostatistical approaches as 
well. The results are presented from the perspective of the 
recently rewarded ERC StG grant of the EU. 
As healthcare costs are continuously increasing in 
modern societies, engineering applications represent one 
of the most important solutions to treat this problem. By 
the advancement of computer science large healthcare 
data is available giving direct target to big data researches, 
cloud and parallel computations, but specific, personalized 
therapy possibilities as well. The European Union’s on-
going research program, the H2020 focuses on this 
engineering supported medical challenge i.e. personalized 
medicine defined by the H2020 Advisory Group as “a 
medical model using characterization of individuals”. 
The concept basically is a direct linkage to one of the 
thirteen subdisciplines of biomedical engineering, 
physiological and pathophysiological modeling, 
simulation and control. This field is mostly a basic 
research oriented branch of biomedical engineering, where 
the aim is to understand and mathematically describe 
given physiological mechanisms and human body 
interactions in order to create the possibility of medical 
device implementations, medical software development, 
medical decision support systems or automatic drug 
delivery protocols. Hence, it supports the cyber-medical 
system research concept. 
In general, physiological modelling and control focuses 
on two basic problems: describe the physiological process 
in a mathematical model, detect/choose the corresponding 
signal being able to manipulate the model and identify the 
non-measurable ones. 
By establishing in 2013 the Physiological Controls 
Group1 (PhysCon), Obuda University envisaged to step in 
the above mentioned direction and together with the 
BioTech Research Center of the Obuda University 
(created in 2012) to colligate and integrate the biomedical 
researches at the university. Moreover, the renewed 
                                                          
1 http://physcon.uni-obuda.hu/?q=en 
Computer Engineering MSc curricula started a new 
specialization in medical informatics as well, based on the 
researches and know-how of the mentioned two 
biomedical research entities. 
The research topics of PhysCon focus on four areas: 
diabetes control, targeted molecular based automatic 
tumor control solutions, biostatistics or evidence-based 
medicine related investigations and control solutions for 
hemodialysis machines. 
The challenge of personalized medicine from control 
engineering point of view is to formulate a general control 
framework applicable for most of the cases of the given 
problem, and inside it adapt a fine tuned solution focusing 
on the individual needs. 
PhysCon gained expertise throughout the years in the 
general control solution formulation by using modern 
robust control techniques. This idea lies on hard 
constraints formulation on the neglected model 
uncertainties and was first investigated under PhysCon in 
the artificial pancreas concept. The main idea was to 
create a general control framework for type 1 (insulin-
dependent) diabetes patients. The developed algorithm 
was tested in-silico on real patient data of the Hungarian 
Artificial Pancreas Working Group established by 
PhysCon together with the Hungarian Diabetes 
Association. 
In the meantime, we have improved our research 
concept using novel control techniques on Linear 
Parameter Varying (LPV) modeling and Tensor Product 
(TP) approaches using linear matrix inequalities (LMI) 
based robust solutions. 
Based on the promising results we have started 
investigating the applicability of the control solution in 
other pathophysiological problems as well. This led our 
orientation to tumor control focusing on antiangiogenic 
targeted molecular therapy (ATMT). We have formulated 
our idea as a double optimization control problem: 
minimizing the tumor volume and minimizing the drug 
infusion (costs of therapy) i.e. taming cancer. The research 
concept was recently rewarded by the EU with the most 
prestigious individual research grant the ERC StG. 
The plenary talk will focus on the presentation of the 
PhysCon researches, highlighting the robust control 
perspectives. 
ACKNOWLEDGEMENT 
The work is supported by the European Research 
Council Starting Grant ERC-StG 679681. 
 
INES 2016 • 20th Jubilee IEEE International Conference on Intelligent Engineering Systems • June 30-July 2, 2016  • Budapest, Hungary
– 19 –978-1-5090-1216-9/16/$31.00 ©2016 IEEE
 Levente Kovács • Control Engineering Approaches at Óbuda University for Physiological Problems
– 20 –
